Concepedia

Author

Antonella Napolitano

GlaxoSmithKline (United Kingdom)

Also Known As

Antonella Napolitano, Napolitano, Antonella

38

Publications

1.7K

Citations

20

H-Index

62

Concepts

All Affiliations

GlaxoSmithKline (United Kingdom)University of CambridgeGlaxoSmithKline (United States)Addenbrooke's HospitalResearch Triangle Park Foundation
AN

About

Antonella Napolitano is an author at GlaxoSmithKline (United Kingdom) specializing in medicine, obesity, and physiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

8

8

316

2

Health Sciences

2

2

63

3

Education

1

1

13

4

Language Studies

1

1

13

5

Natural Sciences

1

1

117

Antonella Napolitano

×

25

Publications

1.4K

Citations

19

H-Index

YearCitations

Novel Gut-Based Pharmacology of Metformin in Patients with Type 2 Diabetes Mellitus

Antonella Napolitano, Sam Miller, Andrew W. Nicholls,

PLoS ONE

2014

280

The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans

Boris A. Chizh, M. O'Donnell, Antonella Napolitano,

Pain

2007

244

11β-hydroxysteroid dehydrogenase 1 in adipocytes: Expression is differentiation-dependent and hormonally regulated

Antonella Napolitano, Michael W. Voice, Christopher R.W. Edwards,

The Journal of Steroid Biochemistry and Molecular Biology

1998

117

Neural and Behavioral Effects of a Novel Mu Opioid Receptor Antagonist in Binge-Eating Obese People

Victoria C. Cambridge, Hisham Ziauddeen, Pradeep J. Nathan,

Biological Psychiatry

2012

92

Validation of a Quantitative Magnetic Resonance Method for Measuring Human Body Composition

Antonella Napolitano, Sam R. Miller, Peter R. Murgatroyd,

Obesity

2008

85

Distinct Modulatory Effects of Satiety and Sibutramine on Brain Responses to Food Images in Humans: A Double Dissociation across Hypothalamus, Amygdala, and Ventral Striatum

Paul C. Fletcher, Antonella Napolitano, Andrew Skeggs,

Journal of Neuroscience

2010

73

Opioid Receptor Modulation of Hedonic Taste Preference and Food Intake: A Single‐Dose Safety, Pharmacokinetic, and Pharmacodynamic Investigation With GSK1521498, a Novel μ‐Opioid Receptor Inverse Agonist

Pradeep J. Nathan, Barry V. O’Neill, Mark Bush,

The Journal of Clinical Pharmacology

2011

49

A randomised, single-blind, placebo-controlled, dose-finding safety and tolerability study of the anti-CD3 monoclonal antibody otelixizumab in new-onset type 1 diabetes

Bart Keymeulen, André van Maurik, João J. Oliveira,

Diabetologia

2020

47

Pelvic Pain and Quality of Life of Women With Endometriosis During Quadriphasic Estradiol Valerate/Dienogest Oral Contraceptive: A Patient-Preference Prospective 24-Week Pilot Study

Giovanni Grandi, Anjeza Xholli, Antonella Napolitano,

Reproductive Sciences

2014

42

Differential insulin response to oral glucose tolerance test (OGTT) in overweight/obese polycystic ovary syndrome patients undergoing to myo-inositol (MYO), alpha lipoic acid (ALA), or combination of both

Alessandro D. Genazzani, Alessia Prati, Federico Marchini,

Gynecological Endocrinology

2019

36

Page 1